Dihexa dosage: why there is no established human dose

“What is the dihexa dose?” is the wrong question with a tidy-sounding answer attached to it all over the internet. The honest answer is that there isn’t one. Dihexa has never been given to a person inside a registered clinical trial, which means no dose has ever been tested for safety or benefit in humans, let alone settled on. Everything else on this page exists to explain why the confident numbers you’ll see are not what they appear to be. For what the compound is and what the lab data actually show, start with the dihexa evidence monograph.

There is no validated human dose — full stop

Begin with the load-bearing fact: dihexa has zero published human clinical trials for any indication.^[4] No registered study has administered it to people, measured how the body handles it, or asked which amount produces a benefit without harm. A dose is something a trial establishes; for dihexa, that step has simply never happened. So when a vendor page or forum thread states a milligram figure with the calm authority of a drug label, it is presenting a guess in the costume of a protocol.

Where the only dosing numbers actually come from

The compound did not appear from nowhere. Dihexa was engineered from angiotensin IV through a medicinal-chemistry program aimed at building a metabolically stable, orally active analog that kept the procognitive activity of the parent peptide.^[1][2] The studies behind it dosed rodents, and those doses are reported the way animal pharmacology always is — in milligrams per kilogram of body weight, by oral or intraperitoneal routes, in learning-and-memory models.^[1] That is the entirety of the genuine dosing record: an animal dose, in animal units, for an animal endpoint.

Why a rodent mg/kg figure is not a human dose

It is tempting to take an animal milligram-per-kilogram number, multiply by a person’s body weight, and call the result a dose. That arithmetic is wrong, and dangerously so. Drug exposure does not scale linearly between species: metabolism, clearance and surface-area-to-mass ratios differ enough that a rodent dose routinely over- or under-shoots the human equivalent by large factors. Pharmacologists use formal allometric conversions precisely because a straight body-weight multiplication misleads — and even those conversions only generate a cautious starting point for a first-in-human trial, not a usable dose. For dihexa, no such trial has been run, so there is no human pharmacokinetic data to anchor any of it. A rodent figure is the beginning of a question, not the answer to one.

The community “microdose” numbers are self-experimentation, not protocol

Search around and you will find specific-sounding regimens — small oral microdoses, or dihexa dissolved in a carrier and applied topically for supposed transdermal delivery, often cycled over a handful of days. These should be read for exactly what they are: anecdotes from people experimenting on themselves with an untested compound. They are not derived from any trial, they were not measured against placebo, and their safety was never monitored under controlled conditions. The fact that a number is repeated in many places does not make it validated; it makes it a widely copied guess. Topical use adds its own unknown — how much, if any, actually reaches the bloodstream through skin has not been characterized for dihexa in humans at all.

The unregulated-product problem compounds the dose problem

Even setting aside the missing trials, there is a supply-side trap. Dihexa is not an approved drug; what sells online is typically labeled “for research use only,” placing it outside the prescription and compounding-pharmacy system. That means the milligrams printed on a vial are not guaranteed to be the milligrams inside it — content, purity and identity are unverified. So any dose a person settles on is doubly hypothetical: an unvalidated number, measured out of an unverified product. We walk through that sourcing hazard in where to get peptides safely.

The honest bottom line

Reduced to what the evidence supports: dihexa has no established human dose, because it has no human trials.^[4] The only real dosing data live in rodent studies measured in milligrams per kilogram, and those do not convert into a safe human amount.^[1] The oral and topical microdoses passed around online are untested self-experimentation, the long-term safety is a blank, and the growth-factor mechanism leaves an open question that no study has closed.^[3] The appropriate posture is not to find the right number but to recognize that there isn’t one yet — dihexa belongs in the early-stage research column, not in a dosing schedule. See also our broader read in the dihexa evidence monograph and where it lands against better-studied options in the peptide evidence matrix.